According to reports, the European Commission’s proposal on critical medicinal products, expected on Tuesday 11 March, will include a section on ‘Enabling conditions for investment’ (see other news).
The proposal would stipulate that a project located in the EU involving the creation or increase of manufacturing capacity is considered a strategic project if it meets several criteria, such as creating manufacturing capacity for one or more critical medicinal products or modernising an...